Moon Seok Choi

Moon Seok Choi


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2014 in Gut and Liver
Verified
Journal Article
Open access
JPJun Young Park
Jun Young Park
MCMoon Seok Choi
Moon Seok Choi
YLYoung-Suk Lim
Young-Suk Lim
JPJang Won Park
Jang Won Park
SKSeung Up Kim
Seung Up Kim
BYByung Chul Yoo
Byung Chul Yoo
Inflammatory pseudotumor (IPT) of the liver is a rare disease characterized by chronic infiltration of inflammatory cells. However, the clinical characteristics and outcomes of IPT remain uncertain. Clinical features, image findings, and outcomes of 55 patients with histologically proven IPT were evaluated. They consisted of 26 men and 19 women with median age of 65 years. Serum carcinoembryonal antigen and carbohydrate antigen 19-9 levels were normal in 42 patients (93.3%). Enhanced CT scans indicated poorly defined peripheral enhancement (82.5%) at the arterial phase and poorly defined hyperattenuating lesions with internal hypoattenuating areas at the equilibrium phase (77.0%). Gadolinium-enhancement MRI revealed poorly defined peripheral rim-like enhancement (77.8%). Ten patients underwent surgical resection and 35 were treated conservatively with or without antibiotics. No recurrence was noted after surgical resection during follow-up (1 to 48 months). In all patients who received conservative treatment, complete resolution or size reduction was noted during follow-up (1 to 192 months). CT and MRI provide clues to the diagnosis of IPT in patients with liver masses and normal tumor markers. However, due to the lack of pathognomonic findings, the clinician's suspicion and histological diagnosis are necessary to make an accurate diagnosis of IPT.

22 July 2019 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
DSDong Hyun Sinn
Dong Hyun Sinn
Sung-Eun KimSung-Eun Kim
Sung-Eun Kim
BKBeom Kyung Kim
Beom Kyung Kim
JKJi Hoon Kim
Ji Hoon Kim
MCMoon Seok Choi
Moon Seok Choi

27 December 2013 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
YMYang Won Min
Yang Won Min
JLJun Hee Lee
Jun Hee Lee
GGGeum‐Youn Gwak
Geum‐Youn Gwak
YPYong Han Paik
Yong Han Paik
JLJoon Hyoek Lee
Joon Hyoek Lee
MCMoon Seok Choi
Moon Seok Choi

25 December 2016 in Clinical and Molecular Hepatology
Verified
Journal Article
Open access
PDF file
JCJu-Yeon Cho
Ju-Yeon Cho
MCMoon Seok Choi
Moon Seok Choi
GLGil Sun Lee
Gil Sun Lee
WSWon Sohn
Won Sohn
JAJemma Ahn
Jemma Ahn
SPSeung Woon Paik
Seung Woon Paik
Radiofrequency ablation (RFA) is one of the most frequently applied curative treatments in patients with a single small hepatocellular carcinoma (HCC). However, the clinical significance of and risk factors for early massive recurrence after RFA-a dreadful event limiting further curative treatment-have not been fully evaluated. In total, 438 patients with a single HCC of size ≤3 cm who underwent percutaneous RFA as an initial treatment between 2006 and 2009 were included. Baseline patient characteristics, overall survival, predictive factors, and recurrence after RFA were evaluated. In addition, the incidence, impact on survival, and predictive factors of early massive recurrence, and initial recurrence beyond the Milan criteria within 2 years were also investigated. During the median follow-up of 68.4 months, recurrent HCC was confirmed in 302 (68.9%) patients, with early massive recurrence in 27 patients (6.2%). The 1-, 3-, and 5-year overall survival rates were 95.4%, 84.7%, and 81.8%, respectively, in patients with no recurrence, 99.6%, 86.4%, and 70.1% in patients with recurrence within the Milan criteria or late recurrence, and 92.6%, 46.5%, and 0.05% in patients with early massive recurrence. Multivariable analysis identified older age, Child-Pugh score B or C, and early massive recurrence as predictive of poor overall survival. A tumor size of ≥2 cm and tumor location adjacent to the colon were independent risk factors predictive of early massive recurrence. Early massive recurrence is independently predictive of poor overall survival after RFA in patients with a single small HCC. Tumors sized ≥2 cm and located adjacent to the colon appear to be independent risk factors for early massive recurrence.

1 April 2023 in Clinical and Molecular Hepatology
Verified
Journal Article
Open access
PDF file
MGMyung Ji Goh
Myung Ji Goh
DSDong Hyun Sinn
Dong Hyun Sinn
JKJong Man Kim
Jong Man Kim
MLMin Woo Lee
Min Woo Lee
DHDong Ho Hyun
Dong Ho Hyun
MCMoon Seok Choi
Moon Seok Choi
Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recently revised the practice guidelines for HCC management. However, there are some differences between practice guidelines and real-life clinical practice. In this review, we describe some key recommendations of the 2022 version of practice guidelines and the real-life clinical situation in South Korea, together with discussion about efforts needed to reduce the difference between guidelines and real-life clinical practice.

11 February 2012 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
JLJin Hee Lee
Jin Hee Lee
MCMoon Seok Choi
Moon Seok Choi
GGGeum Yeon Gwak
Geum Yeon Gwak
JLJoon Hyeok Lee
Joon Hyeok Lee
KKKwang Cheol Koh
Kwang Cheol Koh
CPCheol Keun Park
Cheol Keun Park